img

Global Mental Disorders Drugs Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 320 | Industry : Pharma & Healthcare

Publisher : GRD Survey | Format : PDF

Global Mental Disorders Drugs Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Mental Disorders Drugs market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.

This report studies the Mental Disorders Drugs market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Mental Disorders Drugs in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Drugs for Schizophrenia
Antidepressants
Antipsychotics
Anxiolytics
Drugs for the Treatment of Substance and Alcohol Addiction
Drugs for Childhood and Adolescent Mental Illness
Drugs to Treat Cognitive Disorders
Sleep Disorders
Others

Market Snapshot, By Application
Children
Adolescents
Adults

Main Market Players Analyzed in this report, including
Pfizer
Johnson & Johnson
GlaxoSmithKline
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Abbott Laboratories

The study objectives of this report are
To study and analyze the global Mental Disorders Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Mental Disorders Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Mental Disorders Drugs manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Mental Disorders Drugs market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Mental Disorders Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Mental Disorders Drugs are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Mental Disorders Drugs Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Mental Disorders Drugs Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Mental Disorders Drugs

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Mental Disorders Drugs Sales Channel and Distributors Analysis
3.3.1 Mental Disorders Drugs Sales Channel
3.3.2 Mental Disorders Drugs Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Children
3.4.2 Major Buyers in Adolescents
3.5 Mental Disorders Drugs Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Mental Disorders Drugs Type Introduction
4.1.1 Drugs for Schizophrenia
4.1.2 Antidepressants
4.1.3 Antipsychotics
4.1.4 Anxiolytics
4.1.5 Drugs for the Treatment of Substance and Alcohol Addiction
4.1.6 Drugs for Childhood and Adolescent Mental Illness
4.1.7 Drugs to Treat Cognitive Disorders
4.1.8 Sleep Disorders
4.1.9 Others
4.2 Global Mental Disorders Drugs Sales by Type 2016-2021
4.3 Global Mental Disorders Drugs Revenue by Type 2016-2021
4.4 Global Mental Disorders Drugs Price by Type 2016-2021

5 Market Segment: by Application
5.1 Mental Disorders Drugs Type Introduction
5.1.1 Children
5.1.2 Adolescents
5.1.3 Adults
5.2 Global Mental Disorders Drugs Sales by Application 2016-2021
5.3 Global Mental Disorders Drugs Revenue by Application 2016-2021
5.4 Global Mental Disorders Drugs Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Mental Disorders Drugs Market by Region
6.1.1 Global Mental Disorders Drugs Sales by Regions
6.1.2 Global Mental Disorders Drugs Revenue by Regions
6.2 North America Mental Disorders Drugs Market 2016-2021
6.3 Europe Mental Disorders Drugs Market 2016-2021
6.4 Asia Pacific Mental Disorders Drugs Market 2016-2021
6.5 South America Mental Disorders Drugs Market 2016-2021
6.6 Middle East and Africa Mental Disorders Drugs Market 2016-2021

7 North America
7.1 North America Mental Disorders Drugs Market by Country 2016-2021
7.1.1 North America Mental Disorders Drugs Sales by Country
7.1.2 North America Mental Disorders Drugs Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Mental Disorders Drugs Market by Country 2016-2021
8.1.1 Europe Mental Disorders Drugs Sales by Country
8.1.2 Europe Mental Disorders Drugs Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Mental Disorders Drugs Market by Country 2016-2021
9.1.1 Asia Pacific Mental Disorders Drugs Sales by Country
9.1.2 Asia Pacific Mental Disorders Drugs Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Mental Disorders Drugs Market by Country 2016-2021
10.1.1 South America Mental Disorders Drugs Sales by Country
10.1.2 South America Mental Disorders Drugs Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Mental Disorders Drugs Market by Country 2016-2021
11.1.1 Middle East and Africa Mental Disorders Drugs Sales by Country
11.1.2 Middle East and Africa Mental Disorders Drugs Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Pfizer
12.1.1 Pfizer Company Information
12.1.2 Pfizer Mental Disorders Drugs Product Portfolio, Specification and Application
12.1.3 Pfizer Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Pfizer Key Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Information
12.2.2 Johnson & Johnson Mental Disorders Drugs Product Portfolio, Specification and Application
12.2.3 Johnson & Johnson Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Johnson & Johnson Key Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Information
12.3.2 GlaxoSmithKline Mental Disorders Drugs Product Portfolio, Specification and Application
12.3.3 GlaxoSmithKline Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 GlaxoSmithKline Key Development
12.4 Eli Lilly
12.4.1 Eli Lilly Company Information
12.4.2 Eli Lilly Mental Disorders Drugs Product Portfolio, Specification and Application
12.4.3 Eli Lilly Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Eli Lilly Key Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Information
12.5.2 Bristol-Myers Squibb Mental Disorders Drugs Product Portfolio, Specification and Application
12.5.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Bristol-Myers Squibb Key Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Information
12.6.2 AstraZeneca Mental Disorders Drugs Product Portfolio, Specification and Application
12.6.3 AstraZeneca Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 AstraZeneca Key Development
12.7 Abbott Laboratories
12.7.1 Abbott Laboratories Company Information
12.7.2 Abbott Laboratories Mental Disorders Drugs Product Portfolio, Specification and Application
12.7.3 Abbott Laboratories Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 AstraZeneca Key Development

13 Global Mental Disorders Drugs Market Forecast by Region by Type and by Application
13.1 Global Mental Disorders Drugs Sales, Revenue Forecast 2022-2027
13.2 Global Mental Disorders Drugs Forecast by Regions
13.2.1 Global Mental Disorders Drugs Sales Forecast by Region 2022-2027
13.2.2 Global Mental Disorders Drugs Revenue Forecast by Region 2022-2027
13.3 Global Mental Disorders Drugs Forecast by Type
13.3.1 Global Mental Disorders Drugs Sales Forecast by Type 2022-2027
13.3.2 Global Mental Disorders Drugs Revenue Forecast by Type 2022-2027
13.3.3 Global Mental Disorders Drugs Price Forecast by Type 2022-2027
13.4 Global Mental Disorders Drugs Forecast by Application
13.4.1 Global Mental Disorders Drugs Sales Forecast by Application 2022-2027
13.4.2 Global Mental Disorders Drugs Revenue Forecast by Application 2022-2027
13.4.3 Global Mental Disorders Drugs Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Mental Disorders Drugs Production Specifications
Table 2: Drivers in Mental Disorders Drugs Market
Table 3: Restraints Mental Disorders Drugs Market
Table 4: Opportunity in Mental Disorders Drugs Market
Table 5: Comparion of Alternative and Mental Disorders Drugs
Table 6: Mental Disorders Drugs Raw Materials Key Suppliers List
Table 7: Mental Disorders Drugs Distributors List
Table 8: Mental Disorders Drugs Major Buyers in Children
Table 9: Mental Disorders Drugs Major Buyers in Adolescents
Table 10: Mental Disorders Drugs Major Buyers in Adults
Table 11: Global Mental Disorders Drugs Sales (K Units) by Type 2016-2021
Table 12: Global Mental Disorders Drugs Sales Market Share by Type 2016-2021
Table 13: Global Mental Disorders Drugs Revenue (Million USD) by Type 2016-2021
Table 14: Global Mental Disorders Drugs Revenue Market Share by Type 2016-2021
Table 15: Global Mental Disorders Drugs Price by Type 2016-2021
Table 16: Global Mental Disorders Drugs Sales (K Units) by Application 2016-2021
Table 17: Global Mental Disorders Drugs Sales Market Share by Application 2016-2021
Table 18: Global Mental Disorders Drugs Revenue (Million USD) by Application 2016-2021
Table 19: Global Mental Disorders Drugs Revenue Market Share by Application 2016-2021
Table 20: Global Mental Disorders Drugs Price by Application 2016-2021
Table 21: Global Mental Disorders Drugs Sales (K Units) by Region 2016-2021
Table 22: Global Mental Disorders Drugs Sales Market Share by Region 2016-2021
Table 23: Global Mental Disorders Drugs Revenue (Million USD) by Region 2016-2021
Table 24: Global Mental Disorders Drugs Revenue Market Share by Region 2016-2021
Table 25: North America Mental Disorders Drugs Sales (K Units) by Country 2016-2021
Table 26: North America Mental Disorders Drugs Sales Market Share by Country 2016-2021
Table 27: North America Mental Disorders Drugs Revenue (Million USD) by Country 2016-2021
Table 28: North America Mental Disorders Drugs Revenue Market Share by Country 2016-2021)
Table 29: Europe Mental Disorders Drugs Sales (K Units) by Country 2016-2021
Table 30: Europe Mental Disorders Drugs Sales Market Share by Country 2016-2021
Table 31: Europe Mental Disorders Drugs Revenue (Million USD) by Country 2016-2021
Table 32: Europe Mental Disorders Drugs Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Mental Disorders Drugs Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Mental Disorders Drugs Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Mental Disorders Drugs Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Mental Disorders Drugs Revenue Market Share by Country 2016-2021)
Table 37: South America Mental Disorders Drugs Sales (K Units) by Country 2016-2021
Table 38: South America Mental Disorders Drugs Sales Market Share by Country 2016-2021
Table 39: South America Mental Disorders Drugs Revenue (Million USD) by Country 2016-2021
Table 40: South America Mental Disorders Drugs Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Mental Disorders Drugs Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Mental Disorders Drugs Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Mental Disorders Drugs Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Mental Disorders Drugs Revenue Market Share by Country 2016-2021)
Table 45 Pfizer Company Information
Table 46 Pfizer Mental Disorders Drugs Product Portfolio, Specification and Application
Table 47 Pfizer Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Johnson & Johnson Company Information
Table 49 Johnson & Johnson Mental Disorders Drugs Product Portfolio, Specification and Application
Table 50 Johnson & Johnson Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 GlaxoSmithKline Company Information
Table 52 GlaxoSmithKline Mental Disorders Drugs Product Portfolio, Specification and Application
Table 53 GlaxoSmithKline Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Eli Lilly Company Information
Table 55 Eli Lilly Mental Disorders Drugs Product Portfolio, Specification and Application
Table 56 Eli Lilly Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Bristol-Myers Squibb Company Information
Table 58 Bristol-Myers Squibb Mental Disorders Drugs Product Portfolio, Specification and Application
Table 59 Bristol-Myers Squibb Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 AstraZeneca Company Information
Table 61 AstraZeneca Mental Disorders Drugs Product Portfolio, Specification and Application
Table 62 AstraZeneca Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Abbott Laboratories Company Information
Table 64 Abbott Laboratories Mental Disorders Drugs Product Portfolio, Specification and Application
Table 65 Abbott Laboratories Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Mental Disorders Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Mental Disorders Drugs Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Mental Disorders Drugs Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Mental Disorders Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Mental Disorders Drugs Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Mental Disorders Drugs Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Mental Disorders Drugs Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Mental Disorders Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Mental Disorders Drugs Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Mental Disorders Drugs Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Mental Disorders Drugs Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Mental Disorders Drugs Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Mental Disorders Drugs Picture
Figure 2: Global Mental Disorders Drugs Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Mental Disorders Drugs Supply Chain Analysis
Figure 5: Mental Disorders Drugs Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Drugs for Schizophrenia
Figure 7: Product Picture of Antidepressants
Figure 8: Global Mental Disorders Drugs Sales Market Share by Type, 2020
Figure 9: Global Mental Disorders Drugs Revenue Market Share by Type, 2020
Figure 10: Mental Disorders Drugs in Children
Figure 11: Global Mental Disorders Drugs Market: Children 2016-2021
Figure 12: Mental Disorders Drugs in Adolescents
Figure 13: Global Mental Disorders Drugs Market: Adolescents 2016-2021
Figure 14: Global Mental Disorders Drugs Sales Market Share by Application, 2020
Figure 15: Global Mental Disorders Drugs Revenue Market Share by Application, 2020
Figure 16: Global Mental Disorders Drugs Sales Market Share by Region 2016-2021
Figure 17: Global Mental Disorders Drugs Revenue Market Share by Region 2016-2021
Figure 18: North America Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 19: North America Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 20: Europe Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 21: Europe Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 24: South America Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 25: South America Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 28: North America Mental Disorders Drugs Sales Market Share by Country, 2020
Figure 29: North America Mental Disorders Drugs Revenue Market Share by Country, 2020
Figure 30: United States Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 31: United States Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 32: Canada Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 33: Canada Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 35: Mexico Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 36: Europe Mental Disorders Drugs Sales Market Share by Country, 2020
Figure 37: Europe Mental Disorders Drugs Revenue Market Share by Country, 2020
Figure 38: Germany Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 39: Germany Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 40: France Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 41: France Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 42: UK Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 43: UK Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 44: Italy Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 45: Italy Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 46: Russia Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 46: Russia Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 47: Spain Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 48: Spain Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Mental Disorders Drugs Sales Market Share by Country, 2020
Figure 50: Asia Pacific Mental Disorders Drugs Revenue Market Share by Country, 2020
Figure 51: China Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 52: China Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 53: Japan Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 54: Japan Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 55: Korea Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 56: Korea Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 59: India Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 60: India Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 61: Australia Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 62: Australia Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 63: South America Mental Disorders Drugs Sales Market Share by Country, 2020
Figure 64: South America Mental Disorders Drugs Revenue Market Share by Country, 2020
Figure 65: Brazil Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 66: Brazil Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 68: Argentina Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 70: Colombia Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Mental Disorders Drugs Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Mental Disorders Drugs Revenue Market Share by Country, 2020
Figure 73: Turkey Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 74: Turkey Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Mental Disorders Drugs Sales (K Units) Status 2016-2021
Figure 78: South Africa Mental Disorders Drugs Revenue (Million USD) Status 2016-2021
Figure 79: Pfizer Mental Disorders Drugs Revenue Market Share Globally (2019-2021)
Figure 80: Johnson & Johnson Mental Disorders Drugs Revenue Market Share Globally (2019-2021)
Figure 81: GlaxoSmithKline Mental Disorders Drugs Revenue Market Share Globally (2019-2021)
Figure 82: Eli Lilly Mental Disorders Drugs Revenue Market Share Globally (2019-2021)
Figure 83: Bristol-Myers Squibb Mental Disorders Drugs Revenue Market Share Globally (2019-2021)
Figure 84: AstraZeneca Mental Disorders Drugs Revenue Market Share Globally (2019-2021)
Figure 85: Abbott Laboratories Mental Disorders Drugs Revenue Market Share Globally (2019-2021)
Figure 89: Global Mental Disorders Drugs Sales (K Units) Forecast (2022-2027)
Figure 90: Global Mental Disorders Drugs Sales (K Units) Forecast (2022-2027)